Personalized healthcare: how to improve outcomes by increasing benefit and decreasing risk through the use of biomarkers

Should We Be Applying Warfarin Pharmacogenetics to Clinical Practice? No, Not Now

(2013) Michael H. Rosove   ANNALS OF INTERNAL MEDICINE

KRAS Mutations and Susceptibility to Cetuximab and Panitumumab in Colorectal Cancer

(2010) Antonio Jimeno et al.   CANCER JOURNAL

Translational Toxicology and the Work of the Predictive Safety Testing Consortium

(2009) WB Mattes et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Use of Alzheimer Disease Biomarkers

(2009) Ronald C. Petersen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Novel consortium to address shortfall in innovative medicines for psychiatric disorders

(2009) Bethan Hughes   NATURE REVIEWS DRUG DISCOVERY

Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1

(2009) Joshua S Hunt et al.   PHARMACOTHERAPY

The twin questions of personalized medicine: who are you and whom do you most resemble?

(2009) Isaac S Kohane   Genome Medicine

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study

(2008) P Madadi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CCR5 as Target for HIV-1 Gene Therapy

(2008) Reza Nazari et al.   CURRENT GENE THERAPY

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

(2008) Timothy J. Ley et al.   NATURE

Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum

(2008) Christian Gieger et al.   PLoS Genetics